Farshid G, Balleine RL, Cumming M, Waring P: Morphology of breast cancer as a
means of triage of patients for BRCA1 genetic testing. Am J Surg Pathol
30(11):1357-1366, 2006
http://www.ncbi.nlm.nih.gov/pubmed/17198308?ordinalpos=21&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Livasy CA, Karaca G, Nanda R, et al. Phenotypic evaluation of the basal-like
subtype of invasive breast carcinoma. Modern Pathology 2006; 19: 264-271.
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=16341146&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Rakha EA, El-Sayed, ME, Green, AR, Lee, AHS, Robertson, JF, Ellis, IO:
Prognostic markers in triple-negative breast cancer. Cancer 109(1):25-31, 2007
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17146782&ordinalpos=5&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Werness BA et al. Histopathology, FIGO Stage, and BRCA mutation status of
ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry. Int J
Gynecol Pathol 2004;23:29-34
http://www.ncbi.nlm.nih.gov/pubmed/14668547?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Carcangui ML, Peissel B, Pasini B, Spatti G, Radice P, Manoukian S:
Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line
mutation carriers, with emphasis on fallopian tube lesions. Report of 6 cases
and review of the literature. Am J Surg Pathol 30(10):1222-1230, 2006
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17001151&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Lee Y, Medeiros F, Kindelberger D, Callahan MJ, Muto MG, Crum CP. Advances in
the recognition of tubal intraepithelial carcinoma: applications to cancer
screening and the pathogenesis of ovarian cancer. Adv Anat Pathol 2006
Jan;13(1):1-7.
http://www.ncbi.nlm.nih.gov/pubmed/16462151?ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Umar A. et al. Revised Bethesda Guidelines for hereditary nonpolyposis
colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer
Inst 2004 Feb 18;96(4):261-8.
http://www.ncbi.nlm.nih.gov/pubmed/14970275?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus
Burgart LJ. Testing for defective DNA mismatch repair in colorectal
carcinoma: a practical guide. Arch Pathol Lab Med. 2006 Nov;129(11):1385-9.
http://www.ncbi.nlm.nih.gov/pubmed/16253016?ordinalpos=20&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum\
Jass JR. Classification of colorectal cancer based on correlation of
clinical, morphological and molecular features. Histopathology 2007
Jan;50(1):113-30.
http://www.ncbi.nlm.nih.gov/pubmed/17204026?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Jass JR. What’s new in hereditary colorectal cancer? Arch Pathol Lab Med.
2005 Nov;129(11):1380-4.
http://www.ncbi.nlm.nih.gov/pubmed/16253015?ordinalpos=44&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum